Another notable buy was in Beam Therapeutics Inc (NASDAQ: BEAM ), a biotechnology company specializing in precision genetic medicines. ARK’s ARKK ETF purchased 349,264 shares, adding $6,314,693 in ...

The HP Dimension is the first Google Beam device, and it has a pretty high price of $25,000. It's not available yet.

Currently, the advanced 3D technology only works with Zoom Rooms and Google Meet. HP says its testing has shown that HP Dimension with Google Beam has led to a 28% increase in memory recall and at ...

Set to be the first cancer treatment center of its kind in the Western Hemisphere, Mayo Clinic's Duan Family Building opened on Wednesday, June 11 in Jacksonville, Florida. "The emerging treatments ...

HP unveils the HP Dimension at InfoComm 2025, a $24,999 enterprise system bringing Google's immersive Beam 3D video technology to market to redefine hybrid work with lifelike, glasses-free virtual ...

Gene therapies have ridden investor mania to huge valuations but commercialization challenges have pushed market caps to the ...

The viral immunotherapy delivers a replication-defective herpes simplex virus thymidine kinase gene and was administered in ...

Adding CAN-2409 to standard radiation therapy significantly improved disease-free survival and pathological complete response ...

Beam Therapeutics BEAM announced that the FDA has granted an orphan drug designation to its investigational genome-editing ...

Beam Therapeutics (NASDAQ:BEAM) gains FDA orphan drug status for BEAM-101 to treat sickle cell disease. Read more here.

Beam Therapeutics' investigational modified cell therapy for treating sickle-cell disease has been granted orphan-drug status by the Food and Drug Administration.